US7867001049
US7867001049
Sagimet Biosciences Inc. - Seri
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 633.21M EUR | 477.58M EUR | 170.26M EUR | 192.53M EUR |
Enterprise Value | 316.27M EUR | 313.63M EUR | 133.67M EUR | 157.58M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -6.87x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 2.15x | 1.86x | 1.66x | 1.73x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -- | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -4.39% | -8.74% | -23.33% | -16.16% |